Claim Missing Document
Check
Articles

Found 2 Documents
Search

The use of a Scorecard to Evaluate the Public’s Comprehension of COVID-19: A Pilot Study Kalanjati, Viskasari Pintoko; Hasanatuludhhiyah, Nurina; d'Arqom, Annette; Arsyi, Danial Habri; Permana, Putu Bagus Dharma; Pratiwi, Octaviana Galuh; Farabi, Moh. Reza; Susila, I Made Dwi Yudiartana Putra; Yudhono, Anggit Satriyo; Brilianti, Natasya Nurvita
Jurnal Keperawatan Soedirman Vol 17 No 3 (2022): Jurnal Keperawatan Soedirman (JKS)
Publisher : Fakultas Ilmu-ilmu Kesehatan

Show Abstract | Download Original | Original Source | Check in Google Scholar | Full PDF (231.523 KB) | DOI: 10.20884/1.jks.2022.17.3.6572

Abstract

The rapid spread of information and infodemic might result in public confusion and hinder the handling of the COVID-19 pandemic. Public comprehension of COVID-19 as part of health literacy is an important determinant to filter hoaxes from facts. Therefore, a scoring card called the Karlivid (the COVID-19 literacy and public vaccination scorecard) was developed to evaluate the individual’s comprehension level of COVID-19. A pilot study was conducted with this scoring card. The participants were recruited via consecutive random sampling by using emails from the researcher’s contact list (n=92). A total of 78.3% of the respondents were considered to have an adequate comprehension level. Approximately 77% of all respondents agreed that this card could help them know their comprehension level, 81.5% agreed that this card could improve their comprehension, 81.5% agreed that the items in this card could help them screen facts from hoaxes, and 81.5% agreed that the language used was easily understood by the laypersons. Therefore, the Karlivid is a valid and reliable scorecard that can be used to evaluate public comprehension of COVID-19. Most of the respondents also had a good level of comprehension of this assigned topic
Profile of Patients with Chronic Obstructive Pulmonary Disease (COPD) in Pulmonology Clinic, Universitas Airlangga Hospital, Surabaya, Indonesia, for the Period of January-December 2022 Susila, I Made Dwi Yudiartana Putra; Rosyid, Alfian Nur; Umiastuti, Pirlina; Bakhtiar, Arief
JUXTA: Jurnal Ilmiah Mahasiswa Kedokteran Universitas Airlangga Vol. 17 No. 1 (2026): JANUARY 2026 (IN-PROGRESS ISSUE)
Publisher : Universitas Airlangga

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20473/juxta.V17I12026.15-21

Abstract

Highlights: Chronic obstructive pulmonary disease mainly occurs in male patients, elderly patients, and ex-smokers. Classification of COPD patient therapy must be chosen individually for each patient, which sometimes does not comply with existing guidelines.   Abstract Introduction: Chronic obstructive pulmonary disease (COPD) is a disease-causing breathing issue characterized by persistent and progressive airflow obstruction in response to noxious particles or gases and influenced by host factors. This study aimed to describe the profile trends, including age, sex, body mass index (BMI), complaints, physical examination findings, comorbidities, smoking history, exacerbations, COPD assessment test (CAT) score, modified Medical Research Council (mMRC) dyspnea scale, the Global Initiative for Chronic Obstructive Lung Disease (GOLD)-ABE grouping, and pharmacological therapy. Methods: Data collection included variables such as age, sex, BMI, complaints, physical examination, comorbidities, smoking history, exacerbations, CAT score, mMRC dyspnea scale, GOLD-ABE grouping, and pharmacological therapy. Results: A total of 73 patients were included. The sample was dominated by male patients (84.93%), aged 61-70 years old (38.35%), had normal BMI (63.01%), most complained of persistent cough (57.53%), had normal physical examination (97.26%), had no comorbidities (82.19%), ex-smokers (63.01%), and had no exacerbations (39.72%). Most were classified as Group B (50.68%) in the GOLD-ABE Group, medium (54.79%) on the CAT Score, and grade 1 (42.47%) on the mMRC dyspnea scale. Most patients were treated with long-acting β2-agonist (LABA)+inhaled corticosteroid (ICS) (79.45%) and mucolytics (27.40%). Conclusion: Chronic obstructive pulmonary disease predominantly affected elderly male patients, especially aged 61-70 years old, with a history of smoking. Most had a normal BMI, reported persistent cough, and had no comorbidities. Patients were primarily classified under GOLD-ABE Group B with moderate symptoms, while severe exacerbations were rare. Treatment mainly involved LABA+ICS combinations, though adherence to updated guidelines varied. Further research is needed to refine treatment strategies and to explore additional variables to improve management.